Local interferon‐α gene therapy elicits systemic immunity in a syngeneic pancreatic cancer model in hamster

Cancer Science - Tập 98 Số 3 - Trang 455-463 - 2007
Hidehiko Hara1, Akihiko Kobayashi, Kimiko Yoshida, Masaki Ohashi, Shumpei Ohnami, Takashi Tajiri, Eiji Higashihara, Keitaro Matsuo, Kazunori Aoki
1Section for Studies on Host-Immune Response, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, Japan.

Tóm tắt

The interferon (IFN) protein is a cytokine with pleiotropic biological functions that include induction of apoptosis, inhibition of angiogenesis and immunomodulation. We previously examined the two antitumor mechanisms, taking advantage of the fact that IFN‐α did not show cross‐species activity in its in vivo effect. In a nude mouse subcutaneous xenograft model using human pancreatic cancer cells, the expression of human IFN‐α effectively induced cell death of human pancreatic cancer cells, whereas mouse IFN‐α augmented antitumor immunity by stimulation of natural killer cells. Here, we extended our investigation to a syngeneic pancreatic cancer model, so that the integrated antitumor activity of local IFN‐α gene therapy, including the antiproliferative, proapoptotic, antiangiogeneic and immunomodulatory effects, can be evaluated rigorously. When a recombinant hamster IFN‐α adenovirus was injected into syngeneic subcutaneous tumors of hamster pancreatic cancer (PGHAM‐1) cells in Syrian hamster, tumor growth was significantly suppressed due to cell death and T cell‐ and natural killer cell‐mediated antitumor immunity. Moreover, in this case, tumor regression was observed not only for the injected subcutaneous tumors but also for the untreated tumors both in the peritoneal cavity and at distant sites. No significant systemic toxicity was observed in the treated hamsters. Moreover, the subcutaneous rechallenge of PGHAM‐1 cells was rejected in three of four cured hamsters from the initial tumor challenge. This study further demonstrated that local IFN‐α gene therapy is a promising therapeutic strategy for pancreatic cancer, due to its multiple mechanisms of antitumor activity and its lack of significant toxicity. (Cancer Sci 2007; 98: 455–463))

Từ khóa


Tài liệu tham khảo

Lygidakis NJ, 2005, Adenocarcinoma of the pancreas − past, present and future, Hepatogastroenterology, 52, 1281

10.1053/j.gastro.2005.03.039

10.1200/JCO.2005.23.911

Okusaka T, 2004, New approaches for pancreatic cancer in Japan, Cancer Chemother Pharmacol, 54, S78

10.1111/j.1349-7006.2004.tb03204.x

10.1007/s00268-004-7821-6

Pfeffer LM, 1998, Biological properties of recombinant α‐interferons: 40th anniversary of the discovery of interferons, Cancer Res, 58, 2489

10.1073/pnas.91.4.1198

10.1089/jir.1996.16.759

10.1038/sj.gt.3301949

10.1002/jgm.602

10.1073/pnas.93.9.4513

10.1038/sj.cgt.7700364

10.1038/sj.gt.3301036

10.1089/hum.1998.9.15-2223

10.1038/sj.bjc.6602713

10.1023/A:1023668705040

10.1073/pnas.96.4.1553

10.1038/sj.gt.3301418

10.1111/j.1349-7006.2000.tb01005.x

Mori T, 1994, Characterization of three cloned cell lines from a N‐nitrosobis(2‐hydroxypropyl) amine‐induced transplantable hamster pancreatic ductal adenocarcinoma, Int J Pancreatol, 16, 171, 10.1007/BF02944328

10.1006/mthe.2001.0302

10.1007/BF03402119

Zhang WW, 1995, Detection of wild‐type contamination in a recombinant adenoviral preparation by PCR, Biotechniques, 18, 444

10.1073/pnas.062001899

10.1089/10430349950019200

10.1089/107999001750277871

10.1006/mthe.2002.0629

Indraccolo S, 2002, Gene transfer in ovarian cancer cells: a comparison between retroviral and lentiviral vectors, Cancer Res, 62, 6099

10.1038/sj.gt.3301703

10.1034/j.1600-065X.2001.1810119.x

10.1126/science.1853205

10.1111/j.1399-0039.1996.tb02649.x

10.1097/00006676-200404000-00017

Thông tin
Thông tin xuất bản

Cancer Science

Tập 98 Số 3

455-463

Thông tin tác giả